US Patent 11780881 Compounds for selective disruption of protein-protein interactions
Patent 11780881 was granted and assigned to Synthex, Inc. on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+29 properties)
Article (+377 characters)
US Patent 11780881 Compounds for selective disruption of protein-protein interactions
Article
Patent abstract
The present disclosure provides methods to treat conditions, including cancer, using compounds that can target resistant cancer cells. The compounds can be used to sensitize resistant cancer cells or decrease the proliferation of cells. The compounds can target proteins in the DNA damage repair pathway leading to a decrease in DNA damage repair and cell death.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Charly Chahwan
Maria Soloveychik
Date of Patent
October 10, 2023
Patent Application Number
16876809
Date Filed
May 18, 2020
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11780881 Compounds for selective disruption of protein-protein interactions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.